It is indicated that short‐term blockade of S100A9 can ameliorate post‐MI inflammatory injury and promote cardiac repair, while extended treatment duration can lead to the opposite effect, correlating with a reduction in reparative macrophages due to long‐term S100A9 blockade. Here, S100A9 is linked to myocardial infarction.